相關參考資料

  • ERNEST BEUTLER and Agnes HalaszA Series of New Screening Procedures for Pyruvate Kinase Deficiency, Glucose-6-Phosphate Dehydrogenase Deficiency, and Glutathione Reductase Deficiency. BLOOD, 1966; 28: 553-562<pdf>
  • WHO Working Group, HAEMOGLOBINOPATHIES AND ALLIED DISORDERS. WHO Technical Report Series.1966;338<pdf>
  • WHO Working Group, Standardization of Procedures for the Study of Glucose- 6-Phosphate Dehydrogenase. WHO Technical Report Series.1967;366<pdf>
  • ERNEST BEUTLER and MARGARET MITCHELL. Brief Report: Special Modifications of the Fluorescent Screening Method for Glucose-6-Phosphate Dehydrogenase Deficiency. BLOOD, 1968;32: 816-818<pdf>
  • Gambino SR, Waraksa AJ. An automatic instrument for the measurement of hemoglobin concentration. Am J Clin Pathol. 1969 Nov;52(5):557-64. <pdf>
  • WHO Working Group, TREATMENT OF HAEMOGLOBINOPATHIES AND ALLIED DISORDERS. WHO Technical Report Series.1972;509<pdf>
  • Young DS, Thomas DW, Friedman RB, Pestaner LC. Effects of drugs on clinical laboratory tests. Clin Chem. 1972 Oct;18(10):1041-303.
    <FreeFullText> <pdf>
  • Mei Lee Lowe, Angelo F. Stella, Beatrice S. Mosher, Jerry B. Gin, and James A. Demetriou Microfluorometry of Glucose-6-Phosphate Dehydrogenase and 6-PhosphogluconateDehydrogenasein RedCells.CLIN CHEM, 1972; 18: 440-445<pdf>
  • Lowe ML, Gin JB, Demetriou JA. Stability of erythrocytic enzymes for screening tests. Clin Chem. 1973 May;19(5):529-30. <FreeFullText> <pdf>
  • Nicholson JF, Bodourian SH, Pesce MA. Measurement of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in erythrocytes by use of a centrifugal analyzer. Clin Chem. 1974 Oct;20(10):1349-52. <FreeFullText> <pdf>
  • Catalano EW, Johnson GF, Solomon HM. Measurement of erythrocyte glucose-6-phosphate dehydrogenase activity with a centrifugal analyzer. Clin Chem. 1975 Jan;21(1):134-8. <FreeFullText> <pdf>
  • McComb RB, Bond LW, Burnett RW, Keech RC, Bowers GN Jr. Determination of the molar absorptivity of NADH. Clin Chem. 1976 Feb;22(2):141-50. <abstract> <pdf>
  • Ziegenhorn J, Senn M, Bucher T. Molar absorptivities of beta-NADH and beta-NADPH. Clin Chem. 1976 Feb;22(2):151-60. <abstract> <pdf>
  • E. BEUTLER,K.G.Blume,J.C.KAPLAN,G.W.LOHR, B.RAMOT AND W.N.VALENTINE. International Committee for Satndardization in Haematology: Recommended Methods for Red-Cell Enzyme Analysis. British Journal of Haematology,1977;35:331-340<pdf>
  • Pesce MA, Bodourian SH, Harris RC, Nicholson JF. Enzymatic micromethod for measuring galactose-1-phosphate uridylyltransferase activity in human erythrocytes. Clin Chem. 1977 Sep;23(9):1711-7. <FreeFullText> <pdf>
  • Deutsch J. Maleimide as an inhibitor in measurement of erythrocyte glucose-6-phosphate dehydrogenase activity. Clin Chem. 1978 Jun;24(6):885-9. <FreeFullText> <pdf>
  • Fielek S, Mohrenweiser HW. Erythrocyte enzyme deficiencies assessed with a miniature centrifugal analyzer. Clin Chem. 1979 Mar;25(3):384-8. <FreeFullText> <pdf>
  • Bonderman DP, Proksh GJ, Bonderman PW. Lyophilized control for determination of glucose-6-phosphate dehydrogenase activity in hemolysates. Clin Chem. 1979 May;25(5):815-6. <FreeFullText> <pdf>
  • Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN., International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol. 1979;43:465-7.<pdf>
  • 杜傳書,芮琳.紅細胞葡萄糖-6-磷酸脫氫脢活性的四氮唑藍定量法. 中華血液學雜誌,1981;2:188-192<pdf>
  • 杜傳書,華小云.紅細胞脢測定法及中國人正常值,I.葡糖 6-磷酸脫氫脢及葡糖酸 6-磷酸脫氫脢,中華醫學檢驗雜誌,1985;8:111-113<pdf>
  • Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ. 1989;67(6):601-11. <abstract> <pdf>
  • WHO Working Group, UpdatelLe point Glucose-6-phosphate dehydrogenase deficiency. Bulletin of the World Health Organization, 1989;67: 601-611<pdf>
  • Horder M, Elser RC, Gerhardt W, Mathieu M, Sampson EJ. International Federation of Clinical Chemistry. Scientific Division, Committee on Enzymes. IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2). IFCC recommendations. Clin Chim Acta. 1990 Sep;190(1-2):S4-S40. <pdf> <Appendix A> <Appendix B>
  • Missiou-Tsagaraki S. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants. J Pediatr. 1991 Aug;119(2):293-9. <abstract> <pdf>
  • Meloni T, Forteleoni G, Meloni GF. Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience. Acta Haematol. 1992;87(1-2):29-31. <abstract> <pdf>
  • Yuregir GT, Aksoy K, Arpaci A, Unlukurt I, Tuli A. Studies on red cell glucose-6-phosphate dehydrogenase: evaluation of reference values. Ann Clin Biochem. 1994 Jan;31 ( Pt 1):50-5. <abstract> <pdf>
  • Zwart A, van Assendelft OW, Bull BS, England JM, Lewis SM, Zijlstra WG. Recommendations for reference method for haemoglobinometry in human blood (ICSH standard 1995) and specifications for international haemiglobinocyanide standard (4th edition). J Clin Pathol. 1996 Apr;49(4):271-4. <FreeFullText> <pdf>
  • Michael Kaplan,Chava Leiter,Cathy.Hammerman,and Bernard Rudensky. Comparison of Commercial Screening Tests for Glucose-6-Phosphate Dehydrogenase Deficiency in the Neonatal Period. Clin Chem 1997;43:1236-44<pdf>
  • Kaplan M, Leiter C, Hammerman C, Rudensky B. Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period. Clin Chem. 1997 Jul;43(7):1236-7. <FreeFullText> <pdf>
  • Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero CA, Franck PF, Gella FJ, Hoelzel W, Jorgensen PJ, Kanno T, Kessner A, Klauke R, Kristiansen N, Lessinger JM, Linsinger TP, Misaki H, Panteghini M, Pauwels J, Schiele F, Schimmel HG, Weidemann G, Siekmann L; International Federation of Clinical Chemistry and Laboratory Medicine. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase. Clin Chem Lab Med. 2002 Jul;40(7):725-33. <abstract> <pdf>
  • Zaffanello M, Rugolotto S, Zamboni G, Gaudino R, Tato L. Neonatal screening for glucose-6-phosphate dehydrogenase deficiency fails to detect heterozygote females. Eur J Epidemiol. 2004;19(3):255-7. <abstract> <pdf>
  • International Federation of Clinical Chemistry and Laboratory Medicine (IFCC); Schumann G, Aoki R, Ferrero CA, Ehlers G, Ferard G, Gella FJ, Jorgensen PJ, Kanno T, Kessner A, Klauke R, Kytzia HJ, Lessinger JM, Miller WG, Nagel R, Pauwels J, Schimmel H, Siekmann L, Weidemann G, Yoshida K, Ceriotti F. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Clin Chem Lab Med. 2006;44(9):1146-55. <abstract> <pdf>
  • Ernest Beutler. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008;111:16-24<pdf>
  • Mei-Hwei Chang, Sen-Hui Chen, Ting-Chien Lee. Neonatal Hyperbilirubinemia and Erythrocyte G-6-PD Deficency in Chinese Newborn Infants. Acta Paed Sin 1977;18:1-10.<pdf>
  • Hsiu-Ju Yen, Shu-Jen Chen, Wen-Jue Soong, Mei-Jy Jengm Betau Hwang. Analysis of Test Hemolytic Disease in Newborn with Neonatal Hyperbilirubinemia. Clin Neonatol, 2005;12:1-5<pdf>
  • Shao-Wen Cheng, Ya-Wen Chiu, Yi-Hao Weng. Etiological Analyses of Marked Neonatal Hyperbilirubinemia in A Single Institution in Taiwan, Chang Gung Med J 2012;35:148-54<pdf>